The increased expression of the c-Met/GSK3β/MYC/CCND1 signature in different CRC stages was compared to normal tissues (Figure 2E–G), and p < 0.05 indicated statistical significance (Figure 2H–J). The gene discussed is MET; the disease is colorectal carcinoma.